Delayed Withdrawal of Life-Sustaining Treatment in Disorders of Consciousness: Practical and Theoretical Considerations

被引:0
|
作者
Williams, Aaron [1 ]
Bass, Geoffrey D. [2 ]
Hampton, Stephen [3 ]
Klinedinst, Rachel [4 ]
Giacino, Joseph T. [5 ]
Fischer, David [1 ]
机构
[1] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care, Perelman Sch Med, Philadelphia, PA USA
[3] Univ Penn, Dept Phys Med & Rehabil, Perelman Sch Med, Philadelphia, PA USA
[4] Hosp Univ Penn, Dept Med, Div Palliat Care, Philadelphia, PA USA
[5] Harvard Med Sch, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA USA
关键词
Acute brain injury; Disorder of consciousness; Prognostic factors; Life support care; Withdrawing care; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; INPATIENT REHABILITATION; PROLONGED DISORDERS; VEGETATIVE STATE; RECOVERY; OUTCOMES; DISCHARGE; PROGNOSTICATION; HEALTH;
D O I
10.1007/s12028-024-02143-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Disorders of consciousness (DoC) resulting from severe acute brain injuries may prompt clinicians and surrogate decision makers to consider withdrawal of life-sustaining treatment (WLST) if the neurologic prognosis is poor. Recent guidelines suggest, however, that clinicians should avoid definitively concluding a poor prognosis prior to 28 days post injury, as patients may demonstrate neurologic recovery outside the acute time period. This practice may increase the frequency with which clinicians consider the option of delayed WLST (D-WLST), namely, WLST that would occur after hospital discharge, if the patient's recovery trajectory ultimately proves inconsistent with an acceptable quality of life. However acute care clinicians are often uncertain about what D-WLST entails and therefore find it difficult to properly counsel surrogates about this option. Here, we describe practical and theoretical considerations relevant to D-WLST. We first identify post-acute-care facilities to which patients with DoC are likely to be discharged and where D-WLST may be considered. Second, we describe how clinicians and surrogates may determine the appropriate timing of D-WLST. Third, we outline how D-WLST is practically implemented. And finally, we discuss psychosocial barriers to D-WLST, including the regret paradox, in which surrogates of patients who do not recover to meet preestablished goals frequently choose not to ultimately pursue D-WLST. Together, these practical, logistic, and psychosocial factors must be considered when potentially deferring WLST to the post-acute-care setting to optimize neurologic recovery for patients, avoid prolonged undue suffering, and promote informed and shared decision-making between clinicians and surrogates.
引用
收藏
页码:1064 / 1073
页数:10
相关论文
共 50 条
  • [21] Predicting time to death after withdrawal of life-sustaining therapy
    Munshi, Laveena
    Dhanani, Sonny
    Shemie, Sam D.
    Hornby, Laura
    Gore, Genevieve
    Shahin, Jason
    INTENSIVE CARE MEDICINE, 2015, 41 (06) : 1014 - 1028
  • [22] Is a Good Death Possible After Withdrawal of Life-Sustaining Therapy?
    Wiegand, Debra L.
    Petri, Laura
    NURSING CLINICS OF NORTH AMERICA, 2010, 45 (03) : 427 - +
  • [23] Should Neonatologists Give Opinions Withdrawing Life-sustaining Treatment?
    Blumenthal-Barby, J. S.
    Loftis, Laura
    Cummings, Christy L.
    Meadow, William
    Lemmon, Monica
    Ubel, Peter A.
    McCullough, Laurence
    Rao, Emily
    Lantos, John D.
    PEDIATRICS, 2016, 138 (06)
  • [24] Improving quality of withdrawal of life-sustaining measures in organ donation: a framework and implementation toolkit
    Healey, Andrew
    Hartwick, Michael
    Downar, James
    Keenan, Sean
    Lalani, Jehan
    Mohr, Jim
    Appleby, Amber
    Spring, Jenna
    Delaney, Jesse W.
    Wilson, Lindsay C.
    Shemie, Sam
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2020, 67 (11): : 1549 - 1556
  • [25] Forgoing life-sustaining treatment in an Israeli ICU
    Eidelman, LA
    Jakobson, DJ
    Pizov, R
    Geber, D
    Leibovitz, L
    Sprung, CL
    INTENSIVE CARE MEDICINE, 1998, 24 (02) : 162 - 166
  • [26] Deaths following withdrawal of life-sustaining therapy: Opportunities for quality improvement?
    Guttman, Matthew P.
    Tillmann, Bourke W.
    Haas, Barbara
    Nathens, Avery B.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2020, 89 (04) : 743 - 751
  • [27] Occurrence and timing of withdrawal of life-sustaining measures in traumatic brain injury patients: a CENTER-TBI study
    van Veen, Ernest
    van der Jagt, Mathieu
    Citerio, Giuseppe
    Stocchetti, Nino
    Gommers, Diederik
    Burdorf, Alex
    Menon, David K.
    Maas, Andrew I. R.
    Kompanje, Erwin J. O.
    Lingsma, Hester F.
    INTENSIVE CARE MEDICINE, 2021, 47 (10) : 1115 - 1129
  • [28] Pediatric Death After Withdrawal of Life-Sustaining Therapies: A Scoping Review
    Francoeur, Conall
    Silva, Amina
    Hornby, Laura
    Wollny, Krista
    Lee, Laurie A.
    Pomeroy, Alexandra
    Cayouette, Florence
    Scales, Nathan
    Weiss, Matthew J.
    Dhanani, Sonny
    PEDIATRIC CRITICAL CARE MEDICINE, 2024, 25 (01) : e12 - e19
  • [29] Withdrawal of Life-Sustaining Therapies and Brain Death in the Intensive Care Unit
    Varelas, Panayiotis N.
    Abdelhak, Tamer
    Hacein-Bey, Lotfi
    SEMINARS IN NEUROLOGY, 2008, 28 (05) : 726 - 735
  • [30] Forgoing life-sustaining treatment in an Israeli ICU
    L. A. Eidelman
    D. J. Jakobson
    R. Pizov
    D. Geber
    L. Leibovitz
    C. L. Sprung
    Intensive Care Medicine, 1998, 24 : 162 - 166